Cargando…
Evaluation of Immunogenicity and Clinical Protection of SARS-CoV-2 S1 and N Antigens in Syrian Golden Hamster
The novel coronavirus (SARS-CoV-2) epidemic continues to be a global public crisis affecting human health. Many research groups are developing different types of vaccines to suppress the spread of SARS-CoV-2, and some vaccines have entered phase III clinical trials and have been rapidly implemented....
Autores principales: | Niu, Zhenye, Li, Xueqi, Gao, Yang, Wang, Lichun, Fan, Shengtao, Xu, Xingli, Jiang, Guorun, Cui, Pingfang, Li, Dandan, Liao, Yun, Yu, Li, Zhao, Heng, Zhang, Ying, Li, Qihan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781188/ https://www.ncbi.nlm.nih.gov/pubmed/36560406 http://dx.doi.org/10.3390/vaccines10121996 |
Ejemplares similares
-
Ameliorated immunity elicited by intradermal inoculation in individuals vaccinated with inactivated SARS-CoV-2 vaccine
por: Fan, Shengtao, et al.
Publicado: (2021) -
Generation of transgenic golden Syrian hamsters
por: Gao, Mingming, et al.
Publicado: (2014) -
Golden Syrian Hamster Models for Cancer Research
por: Wang, Zhongde, et al.
Publicado: (2022) -
A HSV1 mutant leads to an attenuated phenotype and induces immunity with a protective effect
por: Xu, Xingli, et al.
Publicado: (2020) -
Long-Term Cross Immune Response in Mice following Heterologous Prime-Boost COVID-19 Vaccination with Full-Length Spike mRNA and Recombinant S1 Protein
por: Li, Dandan, et al.
Publicado: (2023)